Refractory Peripheral T-cell Lymphoma Unspecified

Also known as: Refractory Peripheral T-Cell Lymphoma / Peripheral T-cell lymphoma unspecified refractory

DrugDrug NameDrug Description
DB05015BelinostatA histone deacetylase (HDAC) inhibitor used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
DB06813PralatrexateAn antineoplastic agent used for the treatment of relapsed or refractory peripheral T-cell lymphoma.
DrugDrug NamePhaseStatusCount
DB00531Cyclophosphamide1Not Yet Recruiting1
DB01073Fludarabine1Not Yet Recruiting1
DB08870Brentuximab vedotin2Recruiting1
DB00115Cyanocobalamin2Completed1
DB00158Folic acid2Completed1
DB00441Gemcitabine2Recruiting1
DB00650Leucovorin2Completed1
DB06813Pralatrexate2Completed1
DB04960Tipifarnib2Recruiting1
DB05220Alisertib3Completed1
DB00441Gemcitabine3Completed1
DB06813Pralatrexate3Completed2
DB06176Romidepsin3Completed1